290560 — Sinsiway Co Balance Sheet
0.000.00%
- KR₩29bn
- KR₩13bn
- KR₩12bn
- 97
- 71
- 27
- 76
Annual balance sheet for Sinsiway Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,978 | 6,754 | 6,813 | 13,124 | 16,683 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,196 | 2,205 | 3,089 | 2,293 | 1,624 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,267 | 9,000 | 9,975 | 15,514 | 18,374 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,145 | 4,532 | 4,824 | 4,510 | 4,412 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 15,193 | 16,644 | 17,316 | 22,923 | 25,307 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,858 | 6,034 | 4,978 | 2,814 | 2,438 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5,781 | 6,517 | 5,278 | 3,868 | 2,811 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 9,413 | 10,127 | 12,038 | 19,054 | 22,496 |
Total Liabilities & Shareholders' Equity | 15,193 | 16,644 | 17,316 | 22,923 | 25,307 |
Total Common Shares Outstanding |